Annual fecal immunochemical test-based surveillance could be as effective as colonoscopies in reducing long-term colorectal cancer incidence and mortality, according to a recent study published in ...

Stool-based DNA testing can help bridge CRC screening gaps between rural and urban populations by providing timely follow-up. The study found no significant difference in follow-up times for ...

Noninvasive surveillance with multitarget stool DNA testing or fecal immunochemical testing (FIT) could potentially match colonoscopy for reducing long-term colorectal cancer (CRC) incidence and ...

Please provide your email address to receive an email when new articles are posted on . The multitarget stool DNA test had a positive predictive value of 31.4% for detecting advanced adenomas.

Of the 9989 participants who could be evaluated, 65 (0.7%) had colorectal cancer and 757 (7.6%) had advanced precancerous lesions (advanced adenomas or sessile serrated polyps measuring ≥1 cm in the ...

An estimated 52,500 Americans died last year from colon cancer, yet the disease is highly treatable if it's detected early. Primary care and prevention experts from the U.S. Preventive Services Task ...

CT colonography reduced the incidence of colorectal cancer by up to 75% versus no screening, while stool DNA testing reduced the incidence by 59%. Stool testing was cost-effective relative to no ...

Medicare should cover a parasite poop test when medically necessary, usually when a person has symptoms of gastroenteritis or a history of exposure to a parasite. Laboratory technicians perform a ...

A fecal fat test measures the amount of fat in a person’s stool. The test assesses the digestive function and absorption of fat in the gastrointestinal tract. Several medical conditions cause poor fat ...

(Details of stool collection and processing for DNA testing are shown in Fig. S1 in the Supplementary Appendix, available at NEJM.org.) Buffered stool samples were homogenized, separated into aliquots ...